This article contains information updated as of Feb. 11. President Donald Trump’s recent barrage of executive orders has put ...

Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...

The state's life sciences industry, which generated $3.3 billion in economic activity in 2023, could be severely impacted by ...

The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.

We’re rounding up recent stories, from a court ruling affecting a new National Institutes of Health policy to an increase in ...

After weeks of disruption to scientific federal grants, the National Institutes of Health has fallen behind in funding ...

The National Institutes of Health proposal would limit indirect costs for research projects to 15 percent of grants.